DXB vs RNV

ASX Healthcare sector comparison — updated 25 Mar 2026 — Healthcare sector

DXB

DIMERIX FPO [DXB]

37LOW

RNV

RENERVE FPO [RNV]

37LOW

Score Breakdown

DXB RNV
Technical
51
37
Catalyst
58
52
Sentiment
50
50
Fundamental
82
46
Momentum
39
68
Risk Gate
50
42

Key Metrics

DXB Metric RNV
$198.1MMarket Cap$15.2M
1.2MAvg Volume (20d)142K
+0.1%Short InterestN/A
$0.78552-Week High$0.220
$0.31052-Week Low$0.089
+1.6%Daily Change-4.3%
$0.325Entry Price$0.089
-594.5%ROE-74.9%
-219.9%Profit MarginN/A

Active Signals

DXB Signals

●RSI drifting toward oversold territory — worth watching
●Stochastic is deep in oversold territory — bounce conditions forming
●Trading below both moving averages — the trend is working against this one
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Strong revenue growth (+636%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (4% of range)

RNV Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Sitting right at the lower Bollinger Band — oversold and potentially ready to snap back
●Trading below both moving averages — the trend is working against this one
●Broke below 20-day support — that's a level the market was defending, and it just gave way
●Drifting lower — down 9.2% over the last 5 days
●Below the 200-day average — the long-term trend is still working against it

Ask Scout AI to compare DXB and RNV in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
DXB Full Analysis → RNV Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).